A patient resource to help patients learn more about actinic keratosis (AK) has been launched by PharmaDerm, a division of Nycomed US Inc, Melville, New York. AK Connect contains information tailored to different types of patients about diagnosis, symptoms, treatment, and support for AK. Patients can enroll in the AK Connect program by visiting www.solaraze.com/akconnect. The website provides patients with information about the importance of staying on therapy if diagnosed with AK, being aware of changes on their skin (ie, early diagnosis), and helpful information on protecting the skin from AK lesions.
▴ Information:www.solaraze.com/akconnect© 2011 Lippincott Williams & Wilkins, Inc.